Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

This article is part of the supplement: B cell targeted therapy: a new approach to the treatment of rheumatoid arthritis

Highly Accessed Review

B cell non-Hodgkin's lymphoma: rituximab safety experience

Ann Mohrbacher

Arthritis Research & Therapy 2005, 7(Suppl 3):S19-S25  doi:10.1186/ar1739


  • Last 30 days: 47 accesses
  • Last 365 days: 543 accesses
  • All time: 7609 accesses